These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Congenital abnormalities in two sibs exposed to valproic acid in utero. Chitayat D; Farrell K; Anderson L; Hall JG Am J Med Genet; 1988 Oct; 31(2):369-73. PubMed ID: 3148279 [TBL] [Abstract][Full Text] [Related]
24. Dangers of valproate in pregnancy. Wieck A; Jones S BMJ; 2018 Apr; 361():k1609. PubMed ID: 29669728 [No Abstract] [Full Text] [Related]
25. Possible teratogenic effect of valproate during pregnancy. Koch S; Jäger-Roman E; Rating D; Helge H J Pediatr; 1983 Dec; 103(6):1007-8. PubMed ID: 6417292 [No Abstract] [Full Text] [Related]
27. Sodium valproate and the fetus: a case study and review of the literature. Smith J; Whitehall J Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633 [TBL] [Abstract][Full Text] [Related]
28. The management of epilepsy in women of child-bearing age and the Australian experience of valproate in pregnancy. Curran MA Clin Exp Neurol; 1987; 23():145-8. PubMed ID: 3117457 [TBL] [Abstract][Full Text] [Related]
30. Maternal epilepsy, valproate exposure, and birth defects. Mastroiacovo P; Bertollini R; Morandini S; Segni G Lancet; 1983 Dec 24-31; 2(8365-66):1499. PubMed ID: 6140587 [No Abstract] [Full Text] [Related]
31. Fetal Valproate Syndrome - Still a Problem Today! Wiedemann K; Stüber T; Rehn M; Frieauff E Z Geburtshilfe Neonatol; 2017 Oct; 221(5):243-246. PubMed ID: 29073690 [No Abstract] [Full Text] [Related]
32. Women still not being told about pregnancy risks of valproate. Wise J BMJ; 2017 Sep; 358():j4426. PubMed ID: 28939551 [No Abstract] [Full Text] [Related]
33. The fetal valproate syndrome. Palea KM Scott Med J; 1991 Jun; 36(3):86. PubMed ID: 1925511 [No Abstract] [Full Text] [Related]
34. [Use of valproic acid by pregnant women with epilepsy and the risk of congenital abnormalities in the child]. Niermeijer MF Ned Tijdschr Geneeskd; 1984 Dec; 128(52):2460-1. PubMed ID: 6441121 [No Abstract] [Full Text] [Related]
35. [Facial dysmorphism related to valproic acid ingestion during pregnancy]. Chevallier B; Hertz L; Lagardere B; Gallet JP Arch Fr Pediatr; 1986; 43(7):489-90. PubMed ID: 3099722 [TBL] [Abstract][Full Text] [Related]
36. Spina bifida and in-utero exposure to valproate. Lindhout D; Meinardi H Lancet; 1984 Aug; 2(8399):396. PubMed ID: 6147468 [No Abstract] [Full Text] [Related]
37. The longer term outcome of children born to mothers with epilepsy. Adab N; Kini U; Vinten J; Ayres J; Baker G; Clayton-Smith J; Coyle H; Fryer A; Gorry J; Gregg J; Mawer G; Nicolaides P; Pickering L; Tunnicliffe L; Chadwick DW J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1575-83. PubMed ID: 15491979 [TBL] [Abstract][Full Text] [Related]
38. A case of fetal valproate syndrome with new features expanding the phenotype. Al-Mendalawi MD; Seidahmed MZ Saudi Med J; 2009 Jul; 30(7):977; author reply 977-8. PubMed ID: 19618023 [No Abstract] [Full Text] [Related]
39. Valproate and spina bifida. Robert E; Löfkvist E; Mauguiere F Lancet; 1984 Dec; 2(8416):1392. PubMed ID: 6150384 [No Abstract] [Full Text] [Related]
40. Preaxial polydactyly in the fetal valproate syndrome. Buntinx IM Eur J Pediatr; 1992 Dec; 151(12):919-20. PubMed ID: 1473550 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]